Once disregarded as “junk DNA,” scientists now know that this molecular dark matter is crucial for determining gene activity ...

It could transform our understanding of why diseases develop and the medicines needed to treat them, says researchers.

Artificial intelligence has gotten a bad reputation lately, and often for good reason. But a team of scientists at Google’s ...

Google DeepMind’s Dawn Bloxwich and Tom Lue join "The Tech Download" to explore one of the biggest questions in technology ...

Hackathons using AlphaGenome and other AI models are hunting down the genetic causes of devastating conditions that have evaded diagnosis.

Anthropic CEO Dario Amodei said his company is thinking about how to deal with job elimination "in a sensible way." ...

Google DeepMind co-founder and CEO Demis Hassabis joins 'Squawk Box' to discuss the evolution of Gemini in the AI tech race, ...

Google DeepMind Chief Executive Officer Demis Hassabis said Chinese artificial intelligence companies haven’t been able to ...

Hume AI’s CEO, Alan Cowen, will join Google DeepMind along with several top engineers as part of a major licensing deal.

DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...

Researchers reckon it could dramatically accelerate understanding of how DNA influences disease, cancer, and drug discovery.